SHARE

Leo Cancer Care raises oversubscribed $65m Series D to scale upright treatment platform

The medical technology company will use the funding, led by Yu Galaxy with new backer Eventide Asset Management, to expand manufacturing and commercial rollout. Its upright platform spans proton therapy, photon therapy and imaging.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.